TY - JOUR
T1 - Risk factors for long-term mortality of Staphylococcus aureus bacteremia
AU - Yahav, D.
AU - Yassin, S.
AU - Shaked, H.
AU - Goldberg, E.
AU - Bishara, J.
AU - Paul, M.
AU - Leibovici, L.
N1 - Publisher Copyright:
© 2016, Springer-Verlag Berlin Heidelberg.
PY - 2016/5/1
Y1 - 2016/5/1
N2 - Staphylococcus aureus bacteremia (SAB) is a fatal disease. We aimed to describe risk factors for long-term mortality with SAB. We analyzed data from a retrospectively collected database including 1,692 patients with SAB. We considered variables of infection and background conditions for the analysis of long-term survival. The Kaplan–Meier procedure was used for analysis of long-term survival. Variables significantly associated with mortality were analyzed using a Cox regression model. We included 1,692 patients in the analysis. Patients were followed for up to 22 years. Within one year, 62% of patients died and within 5 years 72% died. A total of 82% of patients aged 65 years and older died within 5 years. Independent predictors of long-term mortality were older age (Hazard ratio 1.029, 95% confidence interval 1.022–1.036), female gender (HR 1.302, 95% CI 1.118–1.517), pneumonia or primary/ unknown source of infection (HR 1.441, 95% CI 1.230–1.689), dementia (HR 1.234, 95% CI 1.004–1.516), higher Charlson score (HR 1.155, 95% CI 1.115–1.196), shock at onset (HR 1.776, 95% CI 1.430–2.207) and arrival to hospitalization from an institution (HR 1.319, 95% CI 1.095–1.563). Long-term survival of patients older than 65 years and of women with SAB is severely curtailed.
AB - Staphylococcus aureus bacteremia (SAB) is a fatal disease. We aimed to describe risk factors for long-term mortality with SAB. We analyzed data from a retrospectively collected database including 1,692 patients with SAB. We considered variables of infection and background conditions for the analysis of long-term survival. The Kaplan–Meier procedure was used for analysis of long-term survival. Variables significantly associated with mortality were analyzed using a Cox regression model. We included 1,692 patients in the analysis. Patients were followed for up to 22 years. Within one year, 62% of patients died and within 5 years 72% died. A total of 82% of patients aged 65 years and older died within 5 years. Independent predictors of long-term mortality were older age (Hazard ratio 1.029, 95% confidence interval 1.022–1.036), female gender (HR 1.302, 95% CI 1.118–1.517), pneumonia or primary/ unknown source of infection (HR 1.441, 95% CI 1.230–1.689), dementia (HR 1.234, 95% CI 1.004–1.516), higher Charlson score (HR 1.155, 95% CI 1.115–1.196), shock at onset (HR 1.776, 95% CI 1.430–2.207) and arrival to hospitalization from an institution (HR 1.319, 95% CI 1.095–1.563). Long-term survival of patients older than 65 years and of women with SAB is severely curtailed.
UR - http://www.scopus.com/inward/record.url?scp=84957959962&partnerID=8YFLogxK
U2 - 10.1007/s10096-016-2598-8
DO - 10.1007/s10096-016-2598-8
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 26873381
AN - SCOPUS:84957959962
SN - 0934-9723
VL - 35
SP - 785
EP - 790
JO - European Journal of Clinical Microbiology and Infectious Diseases
JF - European Journal of Clinical Microbiology and Infectious Diseases
IS - 5
ER -